The PBS ending a 'topsy turvy' decade as two programs

December 16, 2019 Latest News News of the Day

This is a preview of subscriber content

Subscribe now to continue reading.

The BioPharmaDispatch analysis of the recently released annual PBS Expenditure and Prescriptions report has confirmed the challenge of assessing the scheme based on spending growth but confirms how it has effectively transformed into two programs. …

Subscribe now to continue reading.

Latest Video

Opportunity #4 - Scope creep demands stronger checks and balances
August 19, 2026 - Latest News
Opportunity #5 - From the hardest thing to secure to the easiest thing to get right
August 21, 2026 - Latest News
Departmental restructure formally splits medicines financing from pharmacy services
August 19, 2026 - Latest News
CSL absorbs loss in reset year as investors back its plasma-led recovery
August 18, 2026 - Latest News
Novo Nordisk backs care for rural health professionals in southern NSW
August 19, 2026 - Latest News

The PBS ending a 'topsy turvy' decade as two programs

This is a preview of subscriber content

Latest Video

Most Read

Opportunity #4 - Scope creep demands stronger checks and balances

Opportunity #5 - From the hardest thing to secure to the easiest thing to get right

Departmental restructure formally splits medicines financing from pharmacy services

CSL absorbs loss in reset year as investors back its plasma-led recovery

Novo Nordisk backs care for rural health professionals in southern NSW

New Stories

IDT Australia targets profitability after reporting sharply narrowing loss

Opportunity #5 - From the hardest thing to secure to the easiest thing to get right

Biogen bolsters leadership ranks as it sharpens focus on patient access and innovation

Advent moves to acquire majority stake in NZCR Group

Personalised mRNA cancer therapy clears Phase 3 milestone in resected melanoma

New Zealand researchers honoured for work tackling superbugs and blood cancer

Recce advances pivotal diabetic foot infection trial with active antibiotic comparator arm

Sign In

The PBS ending a 'topsy turvy' decade as two programs

This is a preview of subscriber content

Latest Video

Most Read

Opportunity #4 - Scope creep demands stronger checks and balances

Opportunity #5 - From the hardest thing to secure to the easiest thing to get right

Departmental restructure formally splits medicines financing from pharmacy services

CSL absorbs loss in reset year as investors back its plasma-led recovery

Novo Nordisk backs care for rural health professionals in southern NSW

Follow Us

New Stories

IDT Australia targets profitability after reporting sharply narrowing loss

Opportunity #5 - From the hardest thing to secure to the easiest thing to get right

Biogen bolsters leadership ranks as it sharpens focus on patient access and innovation

Advent moves to acquire majority stake in NZCR Group

Personalised mRNA cancer therapy clears Phase 3 milestone in resected melanoma

New Zealand researchers honoured for work tackling superbugs and blood cancer

Recce advances pivotal diabetic foot infection trial with active antibiotic comparator arm